Critical Illness After Hematopoietic Cell Transplantation

NCT07328724 · tracked via the Priya Life Science China tracker

Sponsor

Peking University People's Hospital

Phase

Observational

Started

2026-01-01

Last updated

2026-01-09

Condition(s) studied

Critical IllnessVentilated PatientsHematopoetic Stem Cell TransplantationTransplant Complication

Study summary

This is a prospective, multicenter observational trial for patients who develop critical illness after hematopoietic cell transplantation. Patients who are admitted to the intensive care unit after undergoing hematopoietic cell transplantation at the participating medical centers will be enrolled in this study. The clinical characteristics, laboratory profiles, managements, and clinical outcomes will be prospectively collected.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients who underwent hematopoietic cell transplantation at any of the participating medical centers. * Patients who are admitted to ICU for the management of critical illness following hematopoietic cell transplantation. Exclusion Criteria: * Admitted to ICU for a reason other than critical illness (e.g., routine postoperative monitoring) and discharged within 2 days of ICU admission. * Unavailable in-ICU clinical outcomes or absent key baseline characteristics. * Any other conditions that, in the opinion of the investigator, can interfere with the interpretation of data.

Primary outcome measure(s)

Overall survival — Before ICU discharge; within 6 months after ICU discharge; and within 1 year after ICU discharge.
Overall survival after admission to the intensive care unit.

Trial sites (6)

Facility	City	Region
Peking University People's Hospital	Beijing	China
Xinqiao hospital of the third military medical university	Chongqing	China
First Affiliated Hospital of Zhejiang University	Hangzhou	China
First Affiliated Hospital of Harbin Medical University	Harbin	China
Hematology Hospital of Chinese Academy of Medical Sciences	Tianjin	China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China

More Peking University People's Hospital trials in China

Primary Cervical Cancer Screening by Self-sampling HPV Test Active, not recruiting

Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors Recruiting

Haplo-HSCT for Myelofibrosis Recruiting

Mass Spectrometry-based Immune Profiling in Autoimmune Diseases Enrolling by invitation

PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer Recruiting

Other trials for the same condition

ICCA-Based ICU Physiological State Space Monitor Active, not recruiting

Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm Recruiting

Metabolic and Functional Study of γδ T Cells in Critically Ill Patients Recruiting

Effects of Dexmedetomidine on Sublingual Microcirculation and Vascular Waterfall Phenomenon in Patients With Septic Shock Starting soon

Predicting Adverse Kidney Events of Cardiac Surgery-Associated Acute Kidney Injury Using Novel Biomarkers Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07328724 on ClinicalTrials.gov ↗ ← All trials in China